Skip to search formSkip to main contentSkip to account menu

PND 1186

Known as: VS-4718, PND-1186, FAK Inhibitor VS-4718 
An orally bioavailable focal adhesion kinase (FAK) inhibitor with potential antineoplastic activity. Upon administration, VS-4718 inhibits FAK… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Because cancer stem cells (CSCs) have been implicated in chemo-resistance, metastasis and tumor recurrence, therapeutic targeting… 
2016
2016
Platinum and taxol administration is standard of care chemotherapy for serous ovarian cancer. Tumor recurrence occurs in a high… 
2015
2015
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA Small cell lung cancer (SCLC) is an extremely… 
2015
2015
Although durable responses to single agent immune checkpoint inhibitors have been reported, additional approaches are needed to… 
2013
2013
e13523 Background: Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that orchestrates cellular signaling through… 
2013
2013
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that orchestrates cellular signaling through integrins and growth… 
2010
2010
Commentary to: PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments Isabelle… 
1991
1991
The Mg 3{ital pns} ({ital n}=10--18) and 3{ital pnd} ({ital n}=9--40) doubly excited {ital J}=1 autoionizing states have been…